Selectable high‐yield recombinant protein production in human cells using a GFP/YFP nanobody affinity support

Matthew J. Schellenberg(Mayo Clinic), R. Scott Williams(University of North Carolina at Chapel Hill), Robert M. Petrovich(National Institutes of Health), Christine C. Malone(National Institutes of Health)
Protein Science
March 26, 2018
10.1002/pro.3409
Cited by 42

Related Papers

A Genetic Map of the Response to DNA Damage in Human Cells
|Cell|2020|576
Deficiency of terminal ADP‐ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
|The EMBO Journal|2013|309
Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1
|Nature Structural & Molecular Biology|2004|231
ZATT (ZNF451)–mediated resolution of topoisomerase 2 DNA-protein cross-links
|Science|2017|170
Recognition and maturation of effector RNAs in a CRISPR interference pathway
|Nature Structural & Molecular Biology|2011|166